Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Gcof pdfw (1 3-11) proper final!


Published on

Event brochure for the upcoming Global Clinical Outsourcing Forum in May, Munich. With presentations, case studies and roundtable discussions from leading industry experts from Genzyme, Pfizer, Antisoma, Merck Serono and Grünenthal amoung others

Published in: Health & Medicine
  • Be the first to comment

  • Be the first to like this

Gcof pdfw (1 3-11) proper final!

  1. 1. Register and pay before 25th February 2011 to get full access to the conference for just €549! Presents the 2nd Annual *Terms Apply Overall very valuable. Topics interesting with valuable new information that is appropriate & relevant to what I am doing now. Apo Pharma Inc. Location: THE WESTIn GRAnD, MUnICH two Day conference: 17TH – 18TH MAy 2011 Pre-conference workshoP Day: 16TH MAy 2011Driving Clinical Development and Speeding Time to Market through Effective RelationshipManagement, Establishing CRO Accountability and Running Trials in BRIC Regions Come away with fresh ideas on how to: Get exclusive insight from leading industry experts including: Develop your outsourcing strategy by exploring the various Dr Larry Blankstein, Senior Director of Sponsor-CRO business models. Access over 5 case studies and Clinical Research, Genzyme discussion focused sessions with pioneers from across the Dr Silvio Klimovsky, Head of Clinical industry including Larry Blankstein, Genzyme Research Argentina and Uruguay, Pfizer Uwe Schneider, Head of Global Sourcing Establish CRO accountability and ensure your expectations Management & GCD Business Support, are met by developing a clear RFP/RFI from the outset. Grünenthal Hear first hand from Annika Ekelow, Outsourcing Manager, Corinne Pala, Vendor Relationship Clinical Operations, Swedish Orphan Biovitrium Manager, Grünenthal Hone your negotiation skills and understand the Pia Sauer Larsen, Outsourcing Manager, LEO Pharma importance of a thoroughly drafted contract in our series of exclusive masterclasses. Discuss directly with Deirdre Hall, Hellen Boering, Director Clinical Research Resources Management, Genzyme Pfizer, Maria Agcaoili, Ascent Pharma Solutions and Roger Joby, 1to1to1 Stig Moller Christensen, International Planning & CRO Manager, ALK Abello Explore the opportunities and complexities of running Christian Hucke, Head of Clincal clinical trials in BRIC and emerging regions with expert insight Operations, Affimed Therapeutics from Argentina, the Philippines and the wider Asia-Pacific Region Roger Joby, Managing Director, 1to1to1 Maximise the efficiency and quality of your clinical Yariv Hefez, Director Global Business development programmes through good relationship Development and Alliance Management, Merck Serono management and trial oversight with expert case studies from Larry Blankstein, Genzyme and Corinne Pala, Grünenthal Annika Ekelow, Outsourcing Manager, Clinical Operations, Swedish Orphan Devise risk sharing partnerships and evaluate the change Biovitrium management implications. Get first hand insight from Mubera Krijezi, Senior Project Manager Yariv Hefez, Director Global Business Development and Phase I Group, Actelion Alliance Management, Merck Serono Mayur Trivedi, Senior Clinical QA Auditor, Antisoma Maria Acagoili, CEO and Founder Ascent Pre-conference Workshop Day: Pharma Solutions (Formerly Director Contracts and Outsourcing, Pfizer) This is a unique opportunity to get in depth insight into the critical factors for successful outsourcing and drug development. Take the Richard Pompe, Group R&D Purchasing time to discuss and share ideas with leading experts in the field of clinical Director, Mylan outsourcing, working in emerging markets and adopting the Deirdre Hall, Director, Global Team Lead right relationship strategy for your organisation. Business Operations, Contracts Workshop A: & Outsourcing, Pfizer Optimising Clinical Development Emerging and Take Off Markets Anne Maria Ylisaari, Head of In and Dr Silvio Klimovsky, Head of Clinical Research Argentina Outsourcing, Orion Pharma and Uruguay, Pfizer Dr Ashish Gawde, Head of Monitoring Negotiation Masterclass & Site Management, India, Taiwan, Roger Joby, Managing Director, 1to1to1 Indonesia and the Philippines, BayerW W W.G L O B A L C L I n I C A L O U T S O U R C I n G .C O M MeDiasPonsor: Partners: +44 (0)20 7368 9300 +44 (0)20 7368 9301
  2. 2. PREconfEREncE WoRkshoP DAy Monday 16th May 2011optimising your clinical Development and Patient recruitment through effectivenegotiation, relationship Management and running trials in emerging MarketsworkshoP a – 10.30 – 13.30 cAsE sTUDyoptimising clinical Development emerging and take off MarketsThis hands-on workshop will enable participants to explore and understand the challenges and opportunitiesassociated with outsourcing clinical trials in Latin America.There will be an interactive case study and hypothetical scenario session where participants will be able to worktogether and share ideas before feeding back to the group.You will walk away from this workshop with new ideas on:• Regulatory and quality assessment in Latin America• Evaluating potential hurdles and taking a preventative approach to avoid delays• Developing a long term strategy in Latin AmericaDr Silvio Klimovsky, Head of Clinical Research Argentina and Uruguay, Pfizernegotiation Masterclass – 14.30 – 17.30This masterclass will provide a practical approach to contract development and negotiation to ensure thatyou get the best start to your working relationship. You will get first hand insight from the full spectrum ofparticipants from big pharma, small to medium sized biotech and the CRO perspective.Roger Joby, Managing Director, 1to1to1 about your workshop Leader Roger is a chartered scientist and a member of the Association for Project Management (APM) and has been involved in the pharmaceutical industry for over 30 years. He has experience in Clinical Operations, Project Management, Proposal Generation and third party contracts at all levels. He has worked as an employee and more recently as a consultant for several Pharmaceutical Companies and Clinical Research Organisations (CROs) Roger also takes an active part in project management research and has published several papers on the role of Earned Value Analysis in clinical research with a colleague Dr. David Bryde (Liverpool JM University). In addition to Earned Value, Roger is also interested in Risk Analysis, Project Pricing, Forecasting and Stakeholder analysis. Why Attend? Explore the latest strategies and approaches for Informative, examples from daily practice. efficient outsourcing and clinical development. Medigene AG Hear from a mix of pharma organisations of all shapes and sizes and share strategies and relationship management approaches. I learned a lot at A good mix of functional areas. For training this conference-the purposes it has been enlightening. topics were interesting. ONO Pharmaceutical UK JanssenW W W.G L O B A L C L I n I C A L O U T S O U R C I n G .C O M +44 (0)20 7368 9300 +44 (0)20 7368 9301
  3. 3. confEREncE DAy onE Tuesday 17th May 201108.15 registration and coffee Panellists:09.00 Pharma iQ’s welcome and opening remarks from chairperson Dr silvio klimovsky, Head of Clinical Research Uwe schneider, Head of Global Sourcing Management Argentina and Uruguay, Pfizer & GCD Business Support, Grünenthal Maria agcaoili, CEO, Founder, ascent Pharma solutions (Formerly Director, Contracts & Outsourcing, Pfizer) Uncovering the opportunities and accessing new Populations Dr ashish Gawde, Head of Monitoring & Site Management by running trials in emerging and take off Markets India, Taiwan, Indonesia and the Philippines, Bayer09.10 keynote Presentation: evaluating the future trends in clinical 10.40 networking refreshment Break Development in ‘Pharmerging’ and Latin american regions 11.10 sponsor spotlight sessioncAsE sTUDy • An overview of those regions experiencing a “take off” path in the market growth/life cycle curve This session will be dedicated to a leading service provider • Predicting and investigating the new challenges posed within the clinical field, offering you the opportunity to hear • Tapping into local resources and populations first hand how the latest innovations can help you reach your • Real life examples of trials run in Korea and Latin America drug development goals. Dr silvio klimovsky, Head of Clinical Research, Developing optimal strategies for niche studies Argentina and Uruguay, Pfizer and ensuring cost-efficiency09.40 running clinical trials conducted in the asia-Pacific region 11.40 Understanding when and how to implement • Key challenges and opportunities for running trials in insourcing solutions emerging markets • In-sourcing vs. outsourcing - getting the right balance cAsE sTUDy • An overview of patient recruitment strategies • Saving time and money through recruiting external and opportunities CRAs for multiple, smaller studies • Enhancing trial efficiency through complete understanding • Developing recruitment strategies and accessing of regulations and legislation local talent • The impact of cultural awareness hellen Boering, Director Clinical Research Resources Dr ashish Gawde, Head of Monitoring & Site Management Management, Genzyme India, Taiwan, Indonesia and the Philippines, Bayer 12.10 speed networking – ‘young Guns and old hats‘10.10 PaneL: successfully outsourcing to emerging Markets An opportunity to exchange ideas with other participants at and take off regions different levels of experience to you. This session will be As clinical development and outsourcing become truly divided based upon your experience in the outsourcing field global, how are you maximising the opportunities of and will allow you to forge new contacts and get emerging markets and developing relationships with a fresh perspective. partners in these regions? you can put these questions and 12.40 networking Lunch more to the panel in this interactive discussion about the future of clinical a: stream B:addressing the needs of small and Medium sized organisations addressing the needs of Big Pharma and risk sharing PartnershipCHAIR: Uwe schneider, Head of Global Sourcing Management Development& GCD Business Support, Grünenthal CHAIR: yariv hefez, Director Global Business Development and Alliance Management, Merck serono14.10 establishing optimum selection criteria to enhance the open Discussion session - a risky Business cro selection Process Many big players in the pharma industry are consolidating down • Matching the right CRO to your company and individual trial needs to one or two clinical research partners in order to drive costcAsE sTUDy • Assessing the track record and capabilities of CROs containment and achieve economies of scale. • Can we really maximise clinical development by working This session will allow you to discuss openly with peers as to with a large CRO? the risks and opportunities and how to develop an outsourcing • Setting realistic KPIs from the outset and ensuring these are met strategy to meet your company’s need and pipeline. • Implementing pilot studies to directly assess several partners yariv hefez, Director Global Business Development and Alliance simultaneously and taking a comparative approach Management, Merck serono • Ensuring access to high quality CRAs christian hucke, Head of Clinical Operations, affimed therapeutics14.40 successful relationship Management strategies and successful relationship Management strategies and Gauging efficiency Gauging efficiency • Driving efficiency and trial success through close communication • Facilitating relationship management and communication and relationship management with your trial manager through a reduced number of partners • Setting realistic KPIs and ensuring your project team is on track • Setting realistic KPIs and ensuring your project team is on track • Getting your voice heard throughout the partnership • Achieving cost savings from reduced sponsor oversight requirements corinne Pala, Vendor Relationship Manager, Grünenthal Dr Larry Blankstein, Senior Director of Clinical Research, Genzyme15.10 successful strategies for full outsourcing and establishing establishing an innovative operational risk sharing Partnership cro accountability • Understanding the key drivers for the change to a new • An overview of full vs. functional outsourcing innovative business modelcAsE sTUDy cAsE sTUDy • The role of RFP and contract negotiation in ensuring • An overview of the partnering process expectations are met • The key changes needed in order to implement the new model • Taking a collaborative approach to clinical development • Successfully implementing the change management plan • Transferring accountability to your CRO for patient yariv hefez, Director Global Business Development and Alliance recruitment, site selection etc. Management, Merck serono annika ekelow, Outsourcing Manager, Clinical Operations, swedish orphan Biovitrium15.40 networking refreshment Break16.10 PaneL: assessing the Varying strategies of Different organisations according to size - what can we Learn from each other? This session brings together the findings from the afternoon streams to compare and contrast the different approaches of big and small pharma. A perfect opportunity to share best practices and find out what your peers are doing to drive clinical development. facilitators: Uwe schneider, Head of Global Sourcing Management & GCD Business Support, Grünenthal corrine Pala, Vendor Relationship Manager, Grünenthal Pia sauer Larsen, Outsourcing Manager, Leo Pharma christian hucke, Head of Clincal Operations, affimed therapeutics yariv hefez, Director Global Business Development and Alliance Management, Merck serono17.00 closing remarks from chairperson and end of Day one17.10 networking Drinks reception +44 (0)20 7368 9300 +44 (0)20 7368 9301
  4. 4. confEREncE DAy TWo Wednesday 18th May 201108.15 registration and coffee 14.20 PaneL: how we created the Perfect Partnership This interactive session brings you a real life, working09.00 Pharma iQ’s welcome and opening remarks example of how a sponsor and CRO established the perfect from chairperson deal and partnership from scratch. Engage directly with those who have overcome the challenges and are on their way ensuring appropriate Quality standards and GcP to successful drug development. for clinical trials worldwide Pia sauer Larsen, Outsourcing Manager, Leo Pharma yariv hefez, Director Global Business Development and09.10 Maintaining Quality and GcP standards through Alliance Management, Merck serono effective trial oversight richard Pompe, Group R&D Purchasing Director, MylancAsE sTUDy • The importance of trial oversight to ensure compliance • Understanding GCP levels in emerging markets and 14.50 Breakout roundtable Discussions strategies to ensure high standards Participants will be able to choose one of the roundtables • Our approach: how we monitor trials in various regions outlined below and spend 1hour discussing the points. Mayur trivedi, Senior Clinical QA Auditor, antisoma a) functional vs. full outsourcing - evaluating the Perfecting contract Development and negotiation Best approach for your company strategies in a competitive environment Explore alternative approaches to outsourcing and the pros and cons of functional and full outsourcing strategies. This is09.40 interactiVe workshoP session a perfect opportunity to share, benchmark and discuss the the contract’s role in an outsourcing relationship challenges and solutions with your peers. This session aims to provide better understanding of the Pia sauer Larsen, Outsourcing Manager, Leo Pharma importance of a well-drafted contract to a successful outsourcing relationship. The speakers will impart B) ensuring optimum Patient recruitment through approaches and techniques during contract development effective contract negotiation and setting Milestones that will assist in managing the outsourcing engagement This session will address the challenges of patient throughout the project and there will be an open discussion recruitment and retention and strategies to overcome this in session for a full 20 minutes following the presentation - find a bid to speed trials and time to market. There will be an out all you need to know from the experts! emphasis on setting milestones and KPIs during LearninG oBJectiVes: contract development. • Identify the value of a well-written contract to an stig Moller christensen, International Planning outsourcing relationship. & CRO Manager, aLk abello • Develop familiarity with approaches and techniques in developing an outsourcing contract. c) effective approaches to Measuring Performance • Develop skills to utilise the contract in managing Management an outsourcing relationship. Keeping on track with performance and measuring co-facilitators: milestones will be addressed in this session, where you can Maria agcaoili, CEO, Founder, ascent Pharma solutions explore the necessary steps to achieve a successful study (Formerly Director, Contracts & Outsourcing, Pfizer) that gets results on time. you can get expert insight into Deirdre hall, Director, Global Team Lead Business setting KPIs and how to minimise the impact of problems by Operations, Contracts & Outsourcing, Pfizer spotting them early on. christian hucke, Head of Clinical Operations,11.00 networking refreshment Break affimed therapeutics Guaranteeing success and cost effective clinical 15.50 avoiding Mistakes in cro selection Development through effective relationship Management • Understanding the fundamentals of building and maintaining successful partnerships11.30 relationship Management strategies • Predicting and resolving common sources of conflict • Assessing the effectiveness of micromanagement over a • Evaluating strategies to overcome these issues less formal approach anne Maria ylisaari, Head of In and Outsourcing, • Improving productivity and avoiding delays through orion Pharma good communication • Maintaining quality and ensuring GCP through 16.20 closing remarks from chairperson and end of Day two comprehensive trial oversight Mubera krijezi, Senior Project Manager Phase I Group, actelion Who will attend?12.00 old hats, young Guns - Part two The follow up to yesterday’s introduction, a chance to discuss Directors, senior managers and managers within pharmaceuti- what you’ve gained from the experience and how you can cal manufacturers, biotech, CROs and academic institutes with apply that to what’s going on in your organisation responsibility for: • Outsourcing12.30 sPonsor sPotLiGht session • Clinical Development This session will be dedicated to a leading service provider • Clinical Operations within the clinical field, offering you the opportunity to hear • Vendor Relationship Management first hand how the latest innovations can help you reach your • Contract Management drug development goals. • Alliance Management13.00 networking Lunch Overall very valuable. Topics interesting with valuable new information that is appropriate & relevant to what I am doing now. Apo Pharma Inc.W W W.G L O B A L C L I n I C A L O U T S O U R C I n G .C O M +44 (0)20 7368 9300 +44 (0)20 7368 9301
  5. 5. sPonsoRs AnD ExhibiToRsMAxiMisE yoUR invoLvEMEnT: sPonsoRshiP AnD ExhibiTion oPPoRTUniTiEsPharma IQ’s Global Clinical Outsourcing Forum is the only event Web: that provides dedicated streams to separately address the different Become a member of Pharma IQ and receive complimentary accessneeds and strategies of big pharma and of small to mid sized pharma/ to resources that will keep you at the forefront of industry change.biotech companies. However, as budgets tighten across the globe, You will receive access to our growing library of multi-mediathe industry is looking for the best approach to speed up clinical presentations from industry leaders, an email newsletter updatingdevelopment, get first time approval and ensure their drug reaches you on new content that has been added, free aggregated news feedthe market first. from over 1000 global news sources tracking your industry and special member only discounts on events.The conference is attended by senior officials and decision-makersfrom the outsourcing, clinical and contract management fields,bringing together buyers and suppliers together in one place.Focused and high-level, the event will be an excellent platform Media Partnersto initiate new business relationships. With tailored networking, The International Chamber of Commerce’s Business action to stop counterfeiting and Piracy (BascaP) initiative unites the global businesssponsors can achieve the face-to-face contact that overcrowded community to more efficiently identify and address intellectual property right (IPR) issues and petition for greater commitment by local, nationaltrade shows cannot deliver. and international officials in the enforcement and protection of intellectual property. By delivering compelling messages from corporateExhibiting and sponsorship options are extensive and packages executives across industries, BASCAP underscores the severity of the problem and compels governments and media to take action.can be tailor-made to suit your company’s needs. Packages include to learn more visit entry passes, targeted marketing to industry officials Medical news Today is the largest independent medical and health newsand executives, and bespoke networking opportunities. site on the web - with over 2,500,000 unique monthly users it is ranked number one for medical news on Google and yahoo! Medical news Today is used by Blue Chip pharmaceutical and health organizations, advertising Other features of sponsorship include: agencies, PR companies and vertical ad networks to deliver targeted disease/condition and general health campaigns.• Prominent exhibition space in the main conference for more information contact or visit networking area• Participation in comprehensive pre-event marketing campaigns Adis journals not only offer independent, high-quality content with • Tailored marketing strategies to suit your organisation’s size, enviable impact factors; they also provide an unparalleled evaluation of the available evidence on new and established pharmacological capabilities and individual requirements interventions. Covering all aspects of the drug development continuum from bench-to-bedside, Adis journals are a unique must-have resource for researchers, clinicians, clinical pharmacists and pharmacologists,For more information and to discuss the right teachers, students, and anyone with an interest in independent reviewsopportunity, contact Michael Adeniya on and original research needed to support better therapeutic decisions. Adis journals offer the most comprehensive and objective, evidence-based +44 (0)207 368 9300 or information on: • Clinical pharmacology • Health economics and outcomes • Pharmacovigilance • Biotechnology and personalized medicine – International Pharmaceutical Industry (IPI) IPI was established to fill in the void for effective marketing and communication between all stakeholdersFeatured Exhibitor in the life sciences sector globally. Clients use us due to the extensive knowledge and reach we have built up over the years with our Editor, Editorial Advisory board and market research. We give you links into all areas of Biopharm, Medical, Pharmaceutical and Healthcare. In addition to our extensive reach in the Americas & Europe, we have established a strong presence in the Middle East, Latin America, Eastern Europe, Asia and Africa which are becoming increasingly important to the way the industry is moving forwards in areas of Research and Development, Trials, manufacturing and Technology Transfer. Journal for Clinical Studies – Published bi-monthly, JCS is a unique journal, dedicated to providing information to the global pharmaceutical,The Leading Life Science Logistics Specialists. biotechnology, medical devices and CROs, practical and theoretical operational procedures, challenges, validatory and regulatory guidelinesFounded in 1980, Marken is focused on supporting the premium when conducting trials on a multisite basis and particularly within thelogistics of pharmaceutical, biotechnology and clinical service emerging markets, naïve patient population, and remote access areas. We give you country by country objectives on all disease study areas, butcompanies. Through our strategically placed offices we manage uniquely bring you experiences in developing country diseases such as Liver diseases, kidney diseases, insect borne diseases, malnutrition andthe collection, transport of specimens and distribution of under nutrition. Led by a strong editorial advisory board sourced out fortemperature sensitive clinical trial supplies. Additionally through their experiences, you will get the most practical insight for your global studies. So join us, write for us, feature your experiences with us, advertiseour depot network we support the storage and distribution of your capabilities with us, and ask our advisory board for suggestions andlife science assets. Our team members and network of facilities guidelines. Let us make health care available to all. www.jforcs.combridge the distance between patients and the essential resources Swiss Biotech Association (SBA) was founded in March 1998. Today overof life science companies. 200 companies represent this growing association. SBA is the industry association of small- and medium-sized enterprises active in all areas Marken understands the specialised and dynamic needs of our of biotechnology as well as a very good networking platform for the multinational companies active in the sector. The membership is open toindustry; we retain our global agility by continuously investing companies of various size concerned with different aspects of modern in our people, technologies and global installations to better biotechnology such as R&D, production, marketing and sales, finance, services and consulting. Activities of member companies span differentsupport our clients. sectors of biotechnology including (bio-)pharmaceuticals, diagnostics, agriculture, food, environmental biotechnology, nanotech, nutrition,People marine-oriented research and specialty chemicals.www.swissbiotech.orgWith over 400 people in 25 offices spanning the world, is an efficient, targeted and easy-to-use-“Web2.0”-tool Marken has the expertise to ship globally and deliver locally to for finding the right partners in the pharmaceutical industry worldwide. It saves time and costs in all (out)sourcing and business developmentinvestigator sites or directly to patients. processes, as it facilitates and accelerates the searching process for appropriate business partners significantly. Technologies is particularly advantageous for projects where aOur state of the art management, tracking and information special service is (immediately) required or to offer capacities which are currently available. It is useful for services in all categories and stages ofsystems are second to none offering our clients real time drug development including contract manufacturing, contract research,visibility to the last mile. From hand to hand our chain of custody laboratory investigations, contractual testing, non-clinical and clinical research, active pharmaceutical ingredients, consulting, marketing,reflects our dedication to supporting and exceeding our clients registration, in- and outlicensing etc.expectations. BioM Biotech Cluster Development GmbH serves as the coordinating agency of the Munich Biotech Cluster, and is the top address for allThe combination of expertise, agility, and resources are biotechnology companies and start-ups in the region. The MunichBiotech complemented by our dedication to supporting our clients, their Cluster is a constantly growing hotbed of innovation. The Greater Munich Area counts over 20,000 persons employed by more than 350 companiespatients and the many lives that depend on our services. in the life science sector (Biotech, Pharma, CRO, Suppliers) – plus more than 10,000 scientist in world renowned institutions like Max-Planck, the universitie LMU and TUM - making Munich one of the top regions in Europe. Munich has won a governmental grant in combination with substantial commitment from industry running now a €100 Mio-program in “personalized medicine”: W W.G L O B A L C L I n I C A L O U T S O U R C I n G .C O M +44 (0)20 7368 9300 +44 (0)20 7368 9301
  6. 6. 5 Ways to Register Freephone: 0800 652 2363 or Location: +44 (0)20 7368 9300 THE WESTIn GRAnD, MUnICH two Day conference: 17TH – 18TH MAy 2011 Pre-conference workshoP Day: Fax: +44 (0)20 7368 9301 16TH MAy 2011 post: your booking form to IQPC To speed registration, please provide the priority code located on the mailing label or in the box below. Customer Services My registration code PDFW 129 Wilton Road Victoria, London Please contact our database manager on +44(0) 207 368 9300 or quoting the SW1 V1JZ registration code above to inform us of any changes or to remove your details. Register now for as little as €549! email: stanDarD sUPPLier rates Packages register and pay register and pay register and pay standard by 25th feb* by 25th Mar* by 29th april* Price team Discounts* conference + 2 workshops + full saVe €500 saVe €450 saVe €350 €3747 + VAT access to conference recordings €3247 + VAT €3297 + VAT €3397 + VAT Teams of 3 receive 10% off, Teams of 5 receive 15% off, Teams of 7 receive 20% conference + 1 workshop + full saVe €400 saVe €350 saVe €250 off Team discounts are only available on standard pricing packages and there is only €3098 + VAT access to conference recordings** €2698 + VAT €2748 + VAT €2848 + VAT one discount available per person booking at the same time from the same company saVe €200 saVe €150 conference only €1899 + VAT €1899 + VAT audio recordings €1699 + VAT €1749 + VAT €550 + VAT Venue & accommoDation Venue: The Westin Grand, Munich, Arabellastrasse 6, 81925 München, PharMa anD Biotech ManUfactUrer rates Germany, Tel: +49 89 9264 0, Fax: +49 89 9264 8699 Accommodation: Travel and accommodation are not included in the Packages register and pay register and pay register and pay standard registration fee, however a number of discounted bedrooms have been by 25th feb* by 25th Mar* by 29th april* Price reserved at the Westin Grand Hotel. Please call the hotel directly on conference + 2 workshops + full saVe €1898 saVe €1898 saVe €1698 Tel: + 49 89 92640 and quote booking reference IQPC to receive your €3747 + VAT access to conference recordings €1849 + VAT €1849 + VAT €2049 + VAT discounted rate, prices start from €159 excluding taxes and breakfast. There conference + 1 workshop + full saVe €1649 saVe €1649 saVe €1449 is limited availability so we do encourage attendees to book early to avoid €3098 + VAT access to conference recordings** €1449 + VAT €1449 + VAT €1649 + VAT disappointment. For a further selection of discounted hotels please visit: conference + full access saVe €1600 saVe €1600 saVe €1500 to conference recordings €849 + VAT €849 + VAT €949 + VAT €2449 + VAT conference only saVe €1350 €549 + VAT saVe €1350 €549 + VAT saVe €1250 €649 + VAT €1899 + VAT Free online resources * To qualify for discounts, payments must be received by the early bird registration deadline. To claim a variety of articles, podcasts and other free resources please visit Early booking discounts are not valid in conjunction with any other offer. ** Please select your choice of Workshop: A or the Masterclass ***Tick this box to remove conference recordings and reduce the price by 300 euros German VAT charged at 19%. VAT Registration # DE 261 1019 14 Digital conFerence on cD-rom Delegate Details A digital version of the conference proceedings, including all presentations, Please photocopy for each additional delegate is available to buy. 6 Mr 6 Mrs 6 Miss 6 Ms 6 Dr 6 Other 6 I cannot attend the event, please send me the CD Rom priced at £599 plus VAT Recent digital conferences available - £599 plus VAT each First Name Family Name 6 Innovation in Phase I Clinical Trials Job Title 6 Clinical Data Standardisation and Management Tel No. 6 Innovation in Clinical Design, Analysis and Reporting Email 6 Optimising Clinical Development in Oncology 6 Yes I would like to receive information about products and services via email 6 Optimising Clinical Development for CNS Organisation 6 Clinically Relevant Drug Transporters Nature of business 6 Please send me conference materials indicated above Address 6 I have filled out credit card details opposite Postcode Country For further information Please call: 0207 368 9300 or email: Telephone Fax To search IQPC’s archived conference documentation visit: Approving Manager Name of person completing form if different from delegate: terms anD conDitions Please read the information listed below as each booking is subject to IQPC Ltd standard Signature terms and conditions. Payment Terms: Upon completion and return of the registration form, full payment is required no later than 5 business days from the date of invoice. I agree to IQPC’s cancellation, substitution and payment terms. Payment of invoices by means other than by credit card or purchase order (UK Plc and UK government bodies only) will be subject to a €69 (plus VAT) per delegate processing Special dietary requirements: 6 Vegetarian 6 Non-dairy 6 Other (please specify) fee. Payment must be received prior to the conference date. We reserve the right to refuse Please indicate if you have already registered by Phone 6 Fax 6 Email 6 Web 6 admission to the conference if payment has not been received. IQPC Cancellation, Postponement and Substitution Policy: You may substitute delegates at any time by Please note: if you have not received an acknowledgement before the conference, please call us to confirm your booking. providing reasonable advance notice to IQPC. For any cancellations received in writing not less than eight (8) days prior to the conference, you will receive a 90% credit to be used at another IQPC conference which must occur within one year from the date of issuance of payment methoD such credit. An administration fee of 10% of the contract fee will be retained by IQPC for all permitted cancellations. No credit will be issued for any cancellations occurring within seven Total price for your Organisation: (Add total of all individuals attending): (7) days (inclusive) of the conference. In the event that IQPC cancels an event for any reason,conFerence coDe 18514.002 you will receive a credit for 100% of the contract fee paid. You may use this credit for another IQPC event to be mutually agreed with IQPC, which must occur within one year from the date Card Number: VISA 6 M/C 6 AMEX 6 of cancellation. In the event that IQPC postpones an event for any reason and the delegate 6666666666666666 is unable or unwilling to attend in on the rescheduled date, you will receive a credit for 100% of the contract fee paid. You may use this credit for another IQPC event to be mutually agreed with IQPC, which must occur within one year from the date of postponement. Except Exp. Date: 6 6 6 6 Sec: 6 6 6 6 as specified above, no credits will be issued for cancellations. There are no refunds given under any circumstances. IQPC is not responsible for any loss or damage as a result of a substitution, alteration or cancellation/postponement of an event. IQPC shall assume no Name On Card: Signature: liability whatsoever in the event this conference is cancelled, rescheduled or postponed due to a fortuitous event, Act of God, unforeseen occurrence or any other event that renders Billing Address (if different from below): performance of this conference impracticable, illegal or impossible. For purposes of this clause, a fortuitous event shall include, but not be limited to: war, fire, labour strike, extreme weather or other emergency. Please note that while speakers and topics were confirmed at City/County/Postcode Cheque enclosed for: € (Made payable to IQPC Ltd.) the time of publishing, circumstances beyond the control of the organizers may necessitate substitutions, alterations or cancellations of the speakers and/or topics. As such, IQPC reserves the right to alter or modify the advertised speakers and/or topics if necessary (Please quote 18514.002 with remittance advice) without any liability to you whatsoever. Any substitutions or alterations will be updated on our web page as soon as possible. Discounts: All ‘Early Bird’ Discounts require payment at time IQPC Bank details: HSBC Bank Plc, 67 George Street, Richmond, Surrey, TW9 1HG, United Kingdom of registration and before the cut-off date in order to receive any discount. Any discounts offered by IQPC (including Team Discounts) require payment at the time of Sort Code: 40 05 15 Account No: 59090618 IBAN Code: GB98 MIDL 4005 1559 0906 18 registration. Discount offers cannot be combined with any other offer. Swift Code: MIDLGB22 Account name: International Quality & Productivity Centre Ltd payment must Be receiVeD prior to the conFerence